Skip to main content
. 2019 Oct 4;16(10):e1002891. doi: 10.1371/journal.pmed.1002891

Table 1. Baseline demographic characteristics of participants enrolled in Stage 1 (N = 77) and Stage 2 (N = 61).

Stage 1 Stage 2
Demographic Characteristic All Participants (N = 77) WOT (N = 41) DOT (N = 20) p-Valuea
Age, years Mean (SD) 43 (17) 41 (16) 45 (17) 0.26
Male, N (%) 44 (57%) 21 (51%) 12 (60%) 0.25
Race, N (%) African-American 1 (1%) 0 (0%) 0 (0%) 0.96
Asian 32 (42%) 17 (41%) 8 (40%)
Pacific Islander 1 (1%) 1 (2%) 0 (0%)
White 30 (39%) 14 (34%) 8 (40%)
Unknownb 13 (17%) 9 (22%) 4 (20%)
Ethnicity, N (%) Hispanic/Latino 38 (49%) 21 (51%) 11 (55%) 1
Not Hispanic/Latino 36 (47%) 18 (44%) 8 (40%)
Unknown 3 (4%) 2 (5%) 1 (5%)
Education, N (%) Less than HS 19 (25%) 10 (24%) 4 (20%) 0.96
HS/GED 27 (35%) 14 (35%) 9 (45%)
Some college/technical 20 (26%) 10 (24%) 5 (25%)
Bachelor’s 8 (10%) 5 (12%) 2 (10%)
Advanced 3 (4%) 2 (5%) 0 (0%)
Employment, N (%) Full-time 21 (27%) 12 (29%) 6 (30%) 0.69
Part-time 8 (10%) 5 (12%) 2 (10%)
Unemployed 32 (42%) 18 (44%) 7 (35%)
Retired 4 (5%) 0 (0%) 1 (5%)
Unable to work (disabled) 12 (16%) 6 (15%) 4 (20%)
Average monthly household incomec, N (%) ≤$100 20 (26%) 10 (24%) 7 (35%) 0.42
$101–$500 4 (5%) 0 (0%) 2 (10%)
$501–$1,000 9 (12%) 2 (5%) 2 (10%)
$1,001–$2,000 13 (17%) 8 (20%) 3 (15%)
$2,001–$3,000 7 (9%) 6 (15%) 1 (5%)
$3,001–$4,000 1 (1%) 1 (2%) 0 (0%)
$4,001–$5,000 0 (0%) 0 (0%) 0 (0%)
≥$5,000 2 (3%) 2 (5%) 0 (0%)
Declined to answer 21 (27%) 12 (29%) 5 (25%)

aComparisons between WOT and DOT arms in Stage 2; Wilcoxon rank–sum test was used to compare age, Fisher’s exact test was used for other variables.

bUnknown includes 3 categories: “declined to answer,” “does not know,” and “not available.” The following categories are not shown because all had N = 0: American Indian, Native Alaskan, and Native Hawaiian.

cAll employment groups are included.

Abbreviations: DOT, directly observed therapy; GED, general education development; HS, high school; SD, standard deviation; WOT, wirelessly observed therapy.